Where Are Roche Institute Members Going?

Departing Roche Institute members received severance packages from Hoffmann-La Roche that include bridging grants to help the researchers restart their labs and pay their postdocs, and they are allowed to take essentially all their laboratory equipment with them. This generous offer comes with strings attached, say institute scientists: They must agree not to speak negatively of Hoffmann-La Roche or its officers. If the dispersing scientists hold their tongues--and many would not speak on the

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Departing Roche Institute members received severance packages from Hoffmann-La Roche that include bridging grants to help the researchers restart their labs and pay their postdocs, and they are allowed to take essentially all their laboratory equipment with them. This generous offer comes with strings attached, say institute scientists: They must agree not to speak negatively of Hoffmann-La Roche or its officers.

If the dispersing scientists hold their tongues--and many would not speak on the record to The Scientist--they'll be able to open new labs fully equipped. "And people were nicely equipped at the institute," notes director Herbert Weissbach. Ironically, Roche scientists are at a distinct disadvantage with respect to colleagues working in academia: They have no recent track record of extramural funding, since they never had to apply for grants while at the institute, as they were fully supported by Hoffmann-La Roche.

Following is a list of institute members' new ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies